Letrozol Glenmark 2,5 mg

5,34 53,40 

SKU: N/A Category:



Early estrogen receptor-expressing breast cancer in postmenopausal women – as adjuvant therapy;
early breast cancer in postmenopausal women after completion of standard adjuvant therapy with tamoxifen – as extended adjuvant therapy;
advanced hormone-dependent breast cancer in postmenopausal women – first-line therapy;
advanced breast cancer in postmenopausal women (natural or artificially induced) who have received prior anti-estrogen therapy.
Use during pregnancy and lactation
Contraindicated use during pregnancy and lactation (breastfeeding).


  • Endocrine conditions specific to the reproductive period;
  • lactation (breastfeeding);
  • childhood (efficacy and safety in children has not been established);
  • hypersensitivity to the components of the drug.

Caution: the drug should be used in cases of lactase deficiency, lactase intolerance, glucose-galactose malabsorption syndrome. There are no data on the use of letrozole in patients with a CK < 30 ml/min (the ratio of potential risk to expected treatment effect should be carefully considered before prescribing the drug to such patients).

Additional information

substance active


Amount of substance, mg


formulaire de discharge


1 compressed, mg


Plaquettes thermoformed by package, pieces



Glenmark Drugs GmbH

volume de commande

1 blister of 10 compresses, 1 package (10 blisters), 1 packet (6 blisters)


There are no reviews yet.

Be the first to review “Letrozol Glenmark 2,5 mg”

Your email address will not be published. Required fields are marked *

Select options